MACKOOL ONLINE CME

CME SERIES | SURGICAL VIDEOS

Supported by an unrestricted independent medical educational grant from Alcon
Commercially supported by Carl Zeiss Meditec, Inc., Crestpoint Management, Glaukos, and MST
In kind support by Sony Healthcare Solutions

EPISODE 48 December 2019

Fluidic Options During Phacoemulsification

Satisfactory completion: Learners must pass a post-test and complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Physicians: In support of improving patient care, this activity has been planned and implemented by Amedco LLC and REG (Review Education Group). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Credit Designation Statement - Amedco designates this live activity for a maximum of .25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Financial Disclosure Information: Financial disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content of CME disclosed to PHE. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-­-6.2, 6.5) All planners disclosed they had no financial relationship. Richard J Mackool, MD has the following financial relationships: Consultant: Alcon; Patent Holder: Crestpoint Management, MST
Target Audience: Ophthalmologists with an interest in cataract surgery.
Learning Objectives: Understand the ability to vary the rate of nucleus removal by adjustment of maximum vacuum level
Policy on Privacy and Confidentiality: PHE does not share your personal information provided to this site with any third party, except where required by CME governing bodies for verification of CME activities.
Contact Information: If you have questions regarding any of the surgical videos, please contact us at kmccarthy@postgradhealthed.com
All rights reserved. Video used with permission.

Episode 48: Fluidic Options During Phacoemulsification

In this case, I demonstrate how varying the vacuum setting from 400 to 600 mmHg affects the rate of quadrant removal during phacoemulsification

Richard J Mackool, MD Financial Disclosure: Consultant: Alcon; Patent Holder: Crestpoint Management, MST

TOP